AngioDynamics (ANGO) Tops Q3 EPS by 4c, Offers Guidance
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $13.07 +0.69%
Revenue Growth %: +0.0%
Financial Fact:
Research and development: 6.71M
Today's EPS Names:
EPAC, SAR, KRUS, More
Revenue Growth %: +0.0%
Financial Fact:
Research and development: 6.71M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.02, $0.04 better than the analyst estimate of ($0.02). Revenue for the quarter came in at $71.2 million versus the consensus estimate of $68.95 million.
GUIDANCE:
AngioDynamics sees FY2021 EPS of $0.04-$0.06, versus the consensus of $0.01. AngioDynamics sees FY2021 revenue of $285-288 million, versus the consensus of $283.5 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
- JPMorgan Starts J&T Global Express (1519:HK) at Overweight
- HSBC Reiterates Buy Rating on Samsung Electronics Co Ltd. (005930:KS) (SSNLF)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
